UBS Group
BMEZ icon

UBS Group’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

UBS Group’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
1,064,856
+55,844
+6% +$803K ﹤0.01% 2900
2026
Q1 		$14.5M Sell
1,009,012
-25,779
-2% -$383K ﹤0.01% 2940
2025
Q4 		$15.6M Sell
1,034,791
-40,641
-4% -$610K ﹤0.01% 2820
2025
Q3 		$15.5M Sell
1,075,432
-93,982
-8% -$1.33M ﹤0.01% 2848
2025
Q2 		$16.7M Sell
1,169,414
-53,327
-4% -$762K ﹤0.01% 2566
2025
Q1 		$18.2M Sell
1,222,741
-34,392
-3% -$538K ﹤0.01% 2425
2024
Q4 		$18.1M Sell
1,257,133
-155,991
-11% -$2.41M ﹤0.01% 2438
2024
Q3 		$22.4M Sell
1,413,124
-57,839
-4% -$912K ﹤0.01% 1729
2024
Q2 		$22.6M Buy
1,470,963
+107,384
+8% +$1.63M 0.01% 1589
2024
Q1 		$22.3M Buy
1,363,579
+16,804
+1% +$265K 0.01% 1601
2023
Q4 		$19.7M Sell
1,346,775
-601,965
-31% -$8.4M 0.01% 1596
2023
Q3 		$28.1M Sell
1,948,740
-132,247
-6% -$2.06M 0.01% 1230
2023
Q2 		$34.2M Sell
2,080,987
-99,757
-5% -$1.63M 0.01% 1045
2023
Q1 		$36.4M Buy
2,180,744
+54,442
+3% +$877K 0.01% 965
2022
Q4 		$32.8M Sell
2,126,302
-750,717
-26% -$11.6M 0.01% 1072
2022
Q3 		$43M Sell
2,877,019
-387,890
-12% -$6.42M 0.02% 771
2022
Q2 		$53.6M Sell
3,264,909
-499,689
-13% -$8.57M 0.02% 693
2022
Q1 		$75.5M Sell
3,764,598
-304,007
-7% -$6.31M 0.03% 632
2021
Q4 		$103M Sell
4,068,605
-948,682
-19% -$24.5M 0.03% 586
2021
Q3 		$135M Buy
5,017,287
+287,964
+6% +$8.24M 0.04% 430
2021
Q2 		$137M Buy
4,729,323
+637,344
+16% +$17.6M 0.04% 413
2021
Q1 		$108M Buy
4,091,979
+1,825,203
+81% +$51.8M 0.04% 481
2020
Q4 		$64.9M Buy
2,266,776
+344,095
+18% +$9.15M 0.02% 664
2020
Q3 		$45.9M Buy
1,922,681
+453,793
+31% +$10.5M 0.02% 689
2020
Q2 		$30.7M Buy
1,468,888
+598,283
+69% +$11.8M 0.01% 833
2020
Q1 		$15.6M Buy
+870,605
New +$16.8M 0.01% 1123

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

UBS Group's BMEZ Position: Q2 2026 in Review

UBS Group increased its BlackRock Health Sciences Trust II (BMEZ) stake by 5.5% in Q2 2026, buying an estimated $803K and bringing the position to 1,064,856 shares worth $16.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2900.

UBS Group first reported a position in BMEZ in Q1 2020 and has held it in 26 quarters since. The position peaked at $137M in Q2 2021. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • UBS Group held 1,064,856 shares of BlackRock Health Sciences Trust II worth $16.3M as of Q2 2026.
  • UBS Group bought 55,844 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $803K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2900 holding.
  • UBS Group first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and has held it in 26 quarters since.
  • UBS Group's BlackRock Health Sciences Trust II position peaked at $137M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.